<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sun, 08 Nov 2009 11:53:47 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>Biostar Raises $3.6 Million</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614366</guid>
      <description><![CDATA[Biostar Pharmaceuticals has completed a private placement that raised $3.6 million in new capital. Biostar will use the proceeds to complete its new raw materials processing facility. By taking its raw material production in house, Biostar will lower costs and ensure its product quality. Biostar plans to sell excess raw materials to other pharmaceutical companies in the Shaanxi province.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614366>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 17:26:18 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BSPM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614366</link>
    </item>
    <item>
      <title>Bulls Back On Track?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614255</guid>
      <description><![CDATA[Good morning. With chants of &quot;Dow 10K… Dow 10K&quot; once again rising from the streets at the corner of Broad and Wall yesterday, it is easy to believe that the bulls are back on track and that we'll soon be looking at new highs for the stock market. And when reviewing the data inputs to yesterday's 204 point romp, it is also easy to don the Dow10K hat once again and join in on the celebration.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614255>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 16:21:18 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614255</link>
    </item>
    <item>
      <title>Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614051</guid>
      <description><![CDATA[Ford's 2,215 page 2007 master contract with the UAW 
1941 UAW-Ford contract<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614051>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 13:52:50 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">F</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614051</link>
    </item>
    <item>
      <title>Your Kind of Day?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611831</guid>
      <description><![CDATA[As a rule, I try not to read too terribly much into a &quot;Fed Day&quot; as there is usually a big batch of volatility that may or may not mean much of anything come the dawn of the next day. Maybe, it's just me. Or maybe there are others that find themselves inclined to simply stand aside and watch the nuttiness from the sidelines on &quot;Fed Days.&quot; But in any event, the volatility after a Fed announcement, while fun to watch, may not be telling as to what to expect in the future.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611831>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 19:06:48 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TGT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611831</link>
    </item>
    <item>
      <title>The Dollar-Proof Portfolio</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611744</guid>
      <description><![CDATA[Don't put off this important piece of the financial-planning process.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611744>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 17:31:14 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CEW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GLD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IEO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MON</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STPZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VEU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VSS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VTI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WIP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611744</link>
    </item>
    <item>
      <title>What Investors Should Look for In Today’s Fed Statement</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3605772</guid>
      <description><![CDATA[In its continuing efforts to nurture the fragile economic recovery, the U.S. Federal Reserve is widely expected to leave interest rates at record lows when it concludes its meeting today (Wednesday).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3605772>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 13:04:24 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BCS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ING</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3605772</link>
    </item>
    <item>
      <title>Are Discount Brokers Shares Worth Owning?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3604683</guid>
      <description><![CDATA[The third quarter was a favorable one for the longs. Except for a few short-lived, minor pullbacks stock prices moved higher through the quarter. Stock price volatility declined, takeover activity rose, and risk appetite improved to help the S&amp;P gain 15%.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3604683>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 01:28:03 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMTD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ETFC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SCHB</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3604683</link>
    </item>
    <item>
      <title>Technology Rises And Buying Facebook</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601987</guid>
      <description><![CDATA[Technology stocks have done well this year. The Technology Select Sector SPDR (XLK) bottomed out in March and by late October was up more than 60%.&#160;&#160; Tech has performed better than any other sector year-to-date – up 33.7% as of Friday’s close.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601987>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 16:54:11 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBAY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601987</link>
    </item>
    <item>
      <title>Buffett Gets His Cheque Book Out</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601899</guid>
      <description><![CDATA[Given the slew of positive economic data Monday you might have been forgiven for expecting a decent rebound in risk assets. There was a rebound of sorts in early New York trading, with the Dow up close to 150 points at one stage.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601899>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 16:17:34 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BNI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">F</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INTC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601899</link>
    </item>
    <item>
      <title>Five Ways To Ride The Commodities Bull</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601726</guid>
      <description><![CDATA[Commodity prices have faltered in the last couple of weeks, and much of the “smart money” is saying the boom is over.
Don’t believe it.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601726>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 15:21:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">VALE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601726</link>
    </item>
    <item>
      <title>FDA: Byetta drug label is revised</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3600362</guid>
      <description><![CDATA[FDA: Byetta drug label is revised<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3600362>[More...]</a>]]></description>
      <pubDate>Mon, 02 Nov 2009 20:00:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3600362</link>
    </item>
    <item>
      <title>The Indianapolis Star Daniel Lee Column: Indiana Working to Create Its Own Identity With Investors</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3577876</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 25--Indiana Secretary of Commerce Mitch Roob and some of his staffers at the Indiana Economic Development Corp. have special business cards for out-of-state-trips. &lt;/li&gt;&lt;li&gt;Roob, who leads the IEDC's efforts to attract jobs and money to Indiana, told about talking with a venture capitalist in New York. &lt;/li&gt;&lt;li&gt;It's also a reminder that the state is still a relatively small, if growing, player in attracting the venture capital investments needed to create a lasting high-tech and biotech economy.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3577876>[More...]</a>]]></description>
      <pubDate>Sun, 25 Oct 2009 15:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VC</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3577876</link>
    </item>
    <item>
      <title>Eli Lilly to pay S. Carolina $45 million</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3577576</guid>
      <description><![CDATA[Eli Lilly to pay S. Carolina $45 million<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3577576>[More...]</a>]]></description>
      <pubDate>Sat, 24 Oct 2009 18:38:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3577576</link>
    </item>
    <item>
      <title>Lilly Q3 Net Income Up</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3575305</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Eli Lilly and Company has reported a net income of $941.8 million, or $0.86 per share, for the third quarter ended September 30, 2009, compared to a net loss of $465.6 million, or $0.43 per share, for the third quarter ended September 30, 2008.&lt;/li&gt;&lt;li&gt;Net income for the nine months ended September 30, 2009 was $3.41 billion, or $3.11 per share, compared to $1.56 billion, or $1.42 per share, for the nine months ended September 30, 2008. &lt;/li&gt;&lt;li&gt;Total revenues were $15.9 billion for the nine months ended September 30, 2009, compared to $15.2 billion, for the prior-year period.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3575305>[More...]</a>]]></description>
      <pubDate>Fri, 23 Oct 2009 16:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3575305</link>
    </item>
    <item>
      <title>Eli Lilly CEO banking on new drug pipeline</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3572255</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;And as the oldest of nine children and CEO of a Fortune 500 company, John Lechleiter has a couple under his belt.&lt;/li&gt;&lt;li&gt;Eli Lilly and Co.'s chairman and CEO, Leichleiter brings some of his childhood lessons to bear in leading the major drug company, which is based in Indianapolis.&lt;/li&gt;&lt;li&gt;Management has raised Lilly's 2009 profit outlook twice since July, yet analysts still say the company's future is far from secure.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3572255>[More...]</a>]]></description>
      <pubDate>Thu, 22 Oct 2009 17:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3572255</link>
    </item>
    <item>
      <title>Earnings Preview: Bristol-Myers 3Q earnings report</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3568342</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NEW YORK - Bristol-Myers Squibb Co., the world's No. &lt;/li&gt;&lt;li&gt;The following is a summary of key developments and analyst opinion related to the period.&lt;/li&gt;&lt;li&gt;OVERVIEW: Growing competition for its top drugs threatens revenue for the maker of blood thinner Plavix, the world's second-bestselling medication, and psychiatric drug Abilify.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3568342>[More...]</a>]]></description>
      <pubDate>Wed, 21 Oct 2009 15:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3568342</link>
    </item>
    <item>
      <title>The Business Diary</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3560190</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Tomorrow the National Treasure Management Agency will embark on another fundraising mission with the aim of raising up to [euro]1 billion by auctioning Government bonds.&lt;/li&gt;&lt;li&gt;Results: Apple; Boston Scientific; First Derivatives; Hasbro.&lt;/li&gt;&lt;li&gt;Meeting: Barratt Developments egm; Redrow egm; Social Entrepreneurs Ireland awards presented by President Mary McAleese.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3560190>[More...]</a>]]></description>
      <pubDate>Mon, 19 Oct 2009 05:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MTB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NTRS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVLS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SVU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">T</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">XRX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3560190</link>
    </item>
    <item>
      <title>Drug makers, CVS slammed for promos</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3560042</guid>
      <description><![CDATA[Drug makers, CVS slammed for promos<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3560042>[More...]</a>]]></description>
      <pubDate>Sun, 18 Oct 2009 21:42:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3560042</link>
    </item>
    <item>
      <title>Eli Lilly to sell plant, saving 700 jobs</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3553500</guid>
      <description><![CDATA[Eli Lilly to sell plant, saving 700 jobs<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3553500>[More...]</a>]]></description>
      <pubDate>Wed, 14 Oct 2009 18:30:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3553500</link>
    </item>
    <item>
      <title>Indianapolis Prize 2010 nominees announced</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3535593</guid>
      <description><![CDATA[Indianapolis Prize 2010 nominees announced<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3535593>[More...]</a>]]></description>
      <pubDate>Wed, 07 Oct 2009 16:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3535593</link>
    </item>
    <item>
      <title>ConocoPhillips up 21% Since Added to Galtstock Long-Term Portfolio</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3610365</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Subscribers to galtstock.com &quot;Long-Term Portfolio&quot; service (membership) invest in solid long-term holdings. &lt;/li&gt;&lt;li&gt;Stocks in our portfolio are ConocoPhillips (NYSE: COP), Eli Lilly &amp;amp; Co. (NYSE: LLY), Wal-Mart Stores (NYSE: WMT), and Transocean Ltd. (NYSE: RIG).&lt;/li&gt;&lt;li&gt;To sign up for Galt's Long-Term Portfolio service, please visit the website at http://www.galtstock.com/Long-Term-Portfolio.html with secure check out.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3610365>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 15:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">COP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RIG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WMT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3610365</link>
    </item>
    <item>
      <title>Phase Forward Reports Third Quarter 2009 Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3591497</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data   management solutions for clinical trials and drug safety, today   announced its financial results for the third quarter of 2009.&lt;/li&gt;&lt;li&gt;Within total   revenues, electronic data capture (EDC) license, application hosting and   other related revenues were $38.5 million, representing 71% of third   quarter total non-GAAP revenues and an increase of 18% from $32.7   million in the prior year period.&lt;/li&gt;&lt;li&gt;Weiler added, &quot;During the third quarter, a pharmaceutical company in the   top 40 in sales selected Phase Forward's InForm EDC solution for a   multi-year, multi-million dollar commitment, while a leading provider of   information technology, consulting, and business process outsourcing   services selected InForm as part of their outsourcing services to a top   10 pharma.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3591497>[More...]</a>]]></description>
      <pubDate>Thu, 29 Oct 2009 20:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFWD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3591497</link>
    </item>
    <item>
      <title>Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3571548</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Bristol-Myers   Squibb Company (NYSE:BMY) today reported strong sales and earnings   growth for the third quarter 2009.&lt;/li&gt;&lt;li&gt;&quot;The performance in the third quarter of 2009 clearly shows the results   of our outstanding business performance, disciplined financial   management and overall strategic execution,&quot; said James   M. Cornelius, chairman and chief executive officer. &lt;/li&gt;&lt;li&gt;Third Quarter Performance                                                                                                                2009        2008        Change   Net Sales                                           $  5,487    $  5,254    4%       Net Earnings from Continuing Operations             $  966      $  588      64%      GAAP Diluted EPS from Continuing Operations            0.48        0.29     66%      Non-GAAP Diluted EPS from Continuing Operations        0.52        0.45     16%      ($ amounts in millions, except per share amounts)&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3571548>[More...]</a>]]></description>
      <pubDate>Thu, 22 Oct 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MJN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3571548</link>
    </item>
    <item>
      <title>Licensing Executives Society Announces 2009 Deals of Distinction Awards</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3569701</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Intellectual property (IP) development and the licensing of IP is an   essential component of innovation in our knowledge-based economy. &lt;/li&gt;&lt;li&gt;To highlight the best of these deals, the Licensing Executives Society   (USA &amp; Canada), Inc. (LES) today presented its Deals of DistinctionTM   Awards to winners in five industry sectors. &lt;/li&gt;&lt;li&gt;&quot;Now more than ever, our economy needs intellectual property and the   innovation in products and services that IP helps to achieve,&quot; said   Rimma Driscoll, chair of the LES Deals of Distinction Award Committee.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3569701>[More...]</a>]]></description>
      <pubDate>Wed, 21 Oct 2009 19:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UTHR</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3569701</link>
    </item>
    <item>
      <title>RidgewaterEquity.Com Free Fundamental Sector &amp;Amp; Market Research on ALV, CLS, VIT, TKC, CRK and ALKS</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3546570</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;RidgewaterEquity.com inspires to bring the best from the internet under one roof, providing you with a one click option to view what the market, researchers and financial pundits worldwide have to say about any particular large cap stocks in any given financial environment. &lt;/li&gt;&lt;li&gt;Once you sign up as a free member you will have free unlimited access to all our reports, research tools and more.&lt;/li&gt;&lt;li&gt;We have recently begun in-depth analysis of the following equities &amp;amp; their respective sectors:&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3546570>[More...]</a>]]></description>
      <pubDate>Tue, 13 Oct 2009 12:07:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALKS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CLS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TKC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VIT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3546570</link>
    </item>
    <item>
      <title>Best Practices to Speed-Up Pharmaceutical Analysis Processes From Johnson &amp; Johnson, Pfizer, Genentech and Eli Lilly at Pharma IQ's Forum on Laboratory Informatics</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3515865</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Organized by IQPC,   the 5th   Forum on Laboratory Informatics will be held October 26-28, 2009   in San Francisco, California (www.labinformaticsforum.com).&lt;/li&gt;&lt;li&gt;This forum addresses the fundamental challenges of lab system   integration and interfacing, and is geared towards pharmaceutical and   biotech professionals involved in informatics, lab operations, research   &amp; development, data management and software development.&lt;/li&gt;&lt;li&gt;Leaders from Pfizer, Johnson &amp; Johnson, Eli Lilly,   Millennium (the Takeda Oncology Company), Allergan Pharmaceuticals,   Genentech, PhaseFour Informatics, SmarterLab, Atrium Research &amp;   Consulting will be discussing:&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3515865>[More...]</a>]]></description>
      <pubDate>Wed, 30 Sep 2009 15:53:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3515865</link>
    </item>
    <item>
      <title>PHT Corporation Promotes Dwight Cooper to Vice President of Client Services</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3503124</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;PHT   Corporation, the leading provider of ePRO   solutions used in pharmaceutical and biotechnology clinical trials   worldwide, today announced the promotion of company executive Dwight   Cooper to Vice President of Client Services.&lt;/li&gt;&lt;li&gt;Mr. Cooper joined PHT in   2001 as Director of Engineering. &lt;/li&gt;&lt;li&gt;Mr. Cooper has a   B.S. in Electrical Engineering and an M.S. in Computer Science from   Union College in Schenectady, New York.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3503124>[More...]</a>]]></description>
      <pubDate>Thu, 24 Sep 2009 13:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3503124</link>
    </item>
    <item>
      <title>Teva Provides Update on Generic Evista&amp;#174; Litigation</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3502548</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that   the U.S. District Court for the Southern District of Indiana has issued   a decision invalidating two patents listed in the FDA's Orange Book for   Eli Lilly's Evista&amp;#174; (raloxifene hydrochloride) Tablets in litigation   concerning Teva's abbreviated new drug application to market a generic   version. &lt;/li&gt;&lt;li&gt;The court found these patents to be invalid for lack of written   description.&lt;/li&gt;&lt;li&gt;In the same opinion, the Court rejected Teva's challenges to four   earlier expiring patents, which claim the use of raloxifene for the   prevention or treatment of osteoporosis and the dosages of raloxifene   for such treatment, and found that Teva's generic raloxifene tablets   infringe those other patents.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3502548>[More...]</a>]]></description>
      <pubDate>Thu, 24 Sep 2009 10:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TEVA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3502548</link>
    </item>
    <item>
      <title>Deltagen Reports 2009 Second Quarter Financial Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3492037</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Deltagen, Inc. (Pink Sheets: DGEN), a leading provider of drug discovery   tools to the biopharmaceutical industry, today reported unaudited   consolidated financial results for the three months ended June 30, 2009.&lt;/li&gt;&lt;li&gt;Revenues: The Company's consolidated revenues for the three   months ended June 30, 2009 totaled $0.282 million. &lt;/li&gt;&lt;li&gt;Interest Income: The Company had interest income of $0.004   million for the three months ended June 30, 2009.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3492037>[More...]</a>]]></description>
      <pubDate>Fri, 18 Sep 2009 23:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3492037</link>
    </item>
    <item>
      <title>Transition Therapeutics Announces Fiscal 2009 Year End Financial Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3485772</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;ELND005 (AZD-103) -- Alzheimer's Disease:&lt;/li&gt;&lt;li&gt;&quot;Transition's goal has been to focus on products that have disease modifying characteristics for large disease indications. &lt;/li&gt;&lt;li&gt;These oral small molecule compounds have potential applications in traumatic brain injury, multiple sclerosis and AD,&quot; said Dr. Tony Cruz, Chairman and CEO of Transition.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3485772>[More...]</a>]]></description>
      <pubDate>Wed, 16 Sep 2009 20:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">FMTI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TTHI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3485772</link>
    </item>
    <item>
      <title>Form  4          ALKERMES INC              For: Nov 05  Filed by: BIBERSTEIN KATHRYN L (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614601</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614601>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 18:01:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALKS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614601</link>
    </item>
    <item>
      <title>Form  4          HOOVER R DAVID            For: Oct 30 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3597549</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3597549>[More...]</a>]]></description>
      <pubDate>Mon, 02 Nov 2009 14:03:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3597549</link>
    </item>
    <item>
      <title>Form  4          Fyrwald J Erik            For: Oct 30 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3597547</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3597547>[More...]</a>]]></description>
      <pubDate>Mon, 02 Nov 2009 13:59:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3597547</link>
    </item>
    <item>
      <title>Form  4          ALKERMES INC              For: Oct 06  Filed by: WALL MICHAEL A (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3539618</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3539618>[More...]</a>]]></description>
      <pubDate>Thu, 08 Oct 2009 21:41:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALKS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3539618</link>
    </item>
    <item>
      <title>Form  4          ALKERMES INC              For: Oct 06  Filed by: SKALETSKY MARK B (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3539613</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3539613>[More...]</a>]]></description>
      <pubDate>Thu, 08 Oct 2009 21:38:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALKS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3539613</link>
    </item>
    <item>
      <title>Form  4          ALKERMES INC              For: Oct 06  Filed by: RICH ALEXANDER (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3539609</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3539609>[More...]</a>]]></description>
      <pubDate>Thu, 08 Oct 2009 21:35:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALKS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3539609</link>
    </item>
    <item>
      <title>Form  4          ALKERMES INC              For: Oct 06  Filed by: MITCHELL PAUL J (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3539600</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3539600>[More...]</a>]]></description>
      <pubDate>Thu, 08 Oct 2009 21:29:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALKS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3539600</link>
    </item>
    <item>
      <title>Form  4          ALKERMES INC              For: Oct 06  Filed by: HENWOOD GERALDINE (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3539592</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3539592>[More...]</a>]]></description>
      <pubDate>Thu, 08 Oct 2009 21:24:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALKS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3539592</link>
    </item>
    <item>
      <title>Form  4          ALKERMES INC              For: Oct 06  Filed by: BREYER ROBERT A (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3539586</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3539586>[More...]</a>]]></description>
      <pubDate>Thu, 08 Oct 2009 21:19:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALKS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3539586</link>
    </item>
    <item>
      <title>Form  4          ALKERMES INC              For: Oct 06  Filed by: BLOOM FLOYD E (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3539574</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3539574>[More...]</a>]]></description>
      <pubDate>Thu, 08 Oct 2009 21:13:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALKS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3539574</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=ALKS,AMLN,LLY," rel="self" type="application/rss+xml" />
  </channel>
</rss>